473 Preventive effects of administration of rat luteinizing hormone antibodies on calcium oxalate stone formation in rats treated with the lithogenic factor ethylene glycol

2004 ◽  
Vol 3 (2) ◽  
pp. 121
Author(s):  
P. Tsoumanis ◽  
D. Baltogiannis ◽  
S. Tsambalas ◽  
A. Kafetsoulis ◽  
I. Miyagawa ◽  
...  
2020 ◽  
Vol 54 (1) ◽  
Author(s):  
Althea Samantha C. Agdamag ◽  
Larielyn Hope C. Aggabao ◽  
Mary Sheena C. Agudo ◽  
Francis Louis M. Alcachupas ◽  
Jeremiah Carlo V. Alejo ◽  
...  

Objective. The study aimed to determine if Blumea balsamifera inhibits calcium oxalate stone formation in the kidneys through determination of the number of calcium oxalate stones in the renal cortex and the percent mass of calcium oxalate. Methods. Post-test only control group design was used using five treatment groups with placebo as the negative control, potassium citrate as the positive control, and 50%, 100%, and 200% sambong treatment. Urolithiasis was induced through ethylene glycol and ammonium chloride. Each treatment group was administered its corresponding treatment solution once daily for twenty-one days. Histopathologic examination and kidney homogenate analysis were done to determine the degree of deposition of calcium oxalate stones in renal tissues and the oxalate content, respectively. Statistical analyses were performed using one-way ANOVA and post hoc Gabriel's Pairwise Comparisons Test. Results. The 100% sambong treatment group showed the least mean number of stones while the positive control and 50% sambong treatment group exhibited the highest anti-urolithiatic activity in terms of oxalate content of the kidney homogenate. Conclusion. It can be concluded from the study that Blumea balsamifera inhibits calcium oxalate stone formation in the kidneys with the 100% and 50% sambong treatment most effective in decreasing number of stones and oxalate content of the kidney homogenate, respectively.


1996 ◽  
Vol 156 (2) ◽  
pp. 502-505 ◽  
Author(s):  
Ying Huei Lee ◽  
Wann Chu Huang ◽  
Jong Khing Huang ◽  
Luke S. Chang

2008 ◽  
Vol 81 (3) ◽  
pp. 325-329 ◽  
Author(s):  
Erem Kaan Basok ◽  
Adnan Basaran ◽  
Necmettin Atsu ◽  
Asif Yildirim ◽  
Resit Tokuc

1986 ◽  
Vol 136 (1 Part 1) ◽  
pp. 50-53 ◽  
Author(s):  
Hans-Göran Tiselius ◽  
Lasse Larsson ◽  
Erik Hellgren

1974 ◽  
Vol 47 (1) ◽  
pp. 13-22 ◽  
Author(s):  
W. G. Robertson ◽  
M. Peacock ◽  
R. W. Marshall ◽  
F. Knowles

1. The volume, size and type of calcium oxalate crystals excreted in the urine of a group of patients with recurrent ‘idiopathic’ stones were studied on a controlled basal diet, after an oral supplement of sodium oxalate and after oral administration of ethane-1-hydroxy-1,1-diphosphonate (EHDP) for 4 weeks. 2. Before administration of EHDP the stone-formers passed the large crystals and aggregates of calcium oxalate dihydrate characteristic of recurrent calcium oxalate stone-formers. For the same level of urine saturation and crystalluria EHDP caused a significant reduction in the proportion of large crystals and aggregates excreted. Studies by light-microscopy confirmed that EHDP caused a striking change in the size and habit of calcium oxalate crystals in some but not all of the urine samples examined. 3. The decrease in average crystal size during the administration of EHDP was attributed to the observed increase in the ability of urine to inhibit the growth and aggregation of calcium oxalate crystals as measured by a growth system in vitro. 4. The possible use of EHDP as a therapeutic agent in the treatment of calcium oxalate stone-formation is discussed.


2011 ◽  
Vol 25 (6) ◽  
pp. 1057-1061 ◽  
Author(s):  
Seung Young Oh ◽  
Jong Kyou Kwon ◽  
Seo Yeon Lee ◽  
Moon Soo Ha ◽  
Yong Wook Kwon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document